← Back
Data updated: Mar 10, 2026
EVUS
CardiovascularInfectious DiseaseDermatology
EVUS is a pharmaceutical company focused on Cardiovascular, Infectious Disease, Dermatology.
2006
Since
1
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 38%
1 drugs
Infectious Disease 38%
0 drugs Phase 3: 1 Phase 2: 1
Dermatology 25%
0 drugs Phase 3: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology, Cardiovascular
COSETTE other
Cardiovascular, Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Dermatology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Cardiovascular
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2006-11-02
- Latest
- 2022-06-24
- Applications
- 1